Literature DB >> 24889528

Glial progenitors as targets for transformation in glioma.

Shirin Ilkhanizadeh1, Jasmine Lau1, Miller Huang1, Daniel J Foster2, Robyn Wong1, Aaron Frantz2, Susan Wang2, William A Weiss3, Anders I Persson4.   

Abstract

Glioma is the most common primary malignant brain tumor and arises throughout the central nervous system. Recent focus on stem-like glioma cells has implicated neural stem cells (NSCs), a minor precursor population restricted to germinal zones, as a potential source of gliomas. In this review, we focus on the relationship between oligodendrocyte progenitor cells (OPCs), the largest population of cycling glial progenitors in the postnatal brain, and gliomagenesis. OPCs can give rise to gliomas, with signaling pathways associated with NSCs also playing key roles during OPC lineage development. Gliomas can also undergo a switch from progenitor- to stem-like phenotype after therapy, consistent with an OPC-origin even for stem-like gliomas. Future in-depth studies of OPC biology may shed light on the etiology of OPC-derived gliomas and reveal new therapeutic avenues.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Cancer; Glioblastoma; Glioma; Neural stem cell; Oligodendrocyte progenitor cell

Mesh:

Year:  2014        PMID: 24889528      PMCID: PMC4270964          DOI: 10.1016/B978-0-12-800249-0.00001-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  326 in total

1.  Wnt signaling controls the timing of oligodendrocyte development in the spinal cord.

Authors:  Takeshi Shimizu; Tetsushi Kagawa; Tamaki Wada; Yuko Muroyama; Shinji Takada; Kazuhiro Ikenaka
Journal:  Dev Biol       Date:  2005-06-15       Impact factor: 3.582

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

Review 4.  Not(ch) just development: Notch signalling in the adult brain.

Authors:  Jessica L Ables; Joshua J Breunig; Amelia J Eisch; Pasko Rakic
Journal:  Nat Rev Neurosci       Date:  2011-05       Impact factor: 34.870

5.  Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.

Authors:  Lionel M L Chow; Raelene Endersby; Xiaoyan Zhu; Sherri Rankin; Chunxu Qu; Junyuan Zhang; Alberto Broniscer; David W Ellison; Suzanne J Baker
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

6.  De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Authors:  David Akhavan; Alexandra L Pourzia; Alex A Nourian; Kevin J Williams; David Nathanson; Ivan Babic; Genaro R Villa; Kazuhiro Tanaka; Ali Nael; Huijun Yang; Julie Dang; Harry V Vinters; William H Yong; Mitchell Flagg; Fuyuhiko Tamanoi; Takashi Sasayama; C David James; Harley I Kornblum; Tim F Cloughesy; Webster K Cavenee; Steven J Bensinger; Paul S Mischel
Journal:  Cancer Discov       Date:  2013-03-26       Impact factor: 39.397

7.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

9.  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.

Authors:  David A Gutman; Lee A D Cooper; Scott N Hwang; Chad A Holder; Jingjing Gao; Tarun D Aurora; William D Dunn; Lisa Scarpace; Tom Mikkelsen; Rajan Jain; Max Wintermark; Manal Jilwan; Prashant Raghavan; Erich Huang; Robert J Clifford; Pattanasak Mongkolwat; Vladimir Kleper; John Freymann; Justin Kirby; Pascal O Zinn; Carlos S Moreno; Carl Jaffe; Rivka Colen; Daniel L Rubin; Joel Saltz; Adam Flanders; Daniel J Brat
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

10.  SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function.

Authors:  C Claus Stolt; Anita Schlierf; Petra Lommes; Simone Hillgärtner; Torsten Werner; Thomas Kosian; Elisabeth Sock; Nicoletta Kessaris; William D Richardson; Veronique Lefebvre; Michael Wegner
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

View more
  19 in total

1.  miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.

Authors:  Mengyuan Wang; Ming Hu; Zhaohua Li; Dongmeng Qian; Bin Wang; David X Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-06-07       Impact factor: 3.575

2.  High replication stress and limited Rad51-mediated DNA repair capacity, but not oxidative stress, underlie oligodendrocyte precursor cell radiosensitivity.

Authors:  N Daniel Berger; Peter M Brownlee; Myra J Chen; Hali Morrison; Katalin Osz; Nicolas P Ploquin; Jennifer A Chan; Aaron A Goodarzi
Journal:  NAR Cancer       Date:  2022-04-12

3.  Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma.

Authors:  Nan Li; Dustin J Maly; Yvan H Chanthery; Daniel W Sirkis; Jean L Nakamura; Mitchel S Berger; C David James; Kevan M Shokat; William A Weiss; Anders I Persson
Journal:  Mol Cancer Ther       Date:  2014-12-18       Impact factor: 6.261

4.  Ruta graveolens L. induces death of glioblastoma cells and neural progenitors, but not of neurons, via ERK 1/2 and AKT activation.

Authors:  Maria Teresa Gentile; Claudia Ciniglia; Mafalda G Reccia; Floriana Volpicelli; Monica Gatti; Stefano Thellung; Tullio Florio; Mariarosa A B Melone; Luca Colucci-D'Amato
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 5.  Myeloid-derived suppressor cells in gliomas.

Authors:  Anna Gieryng; Bozena Kaminska
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20

6.  β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability.

Authors:  Elizabeth Harford-Wright; Nicolas Bidère; Julie Gavard
Journal:  Oncotarget       Date:  2016-10-11

7.  Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma.

Authors:  Jiacheng Lu; Hailin Li; Zhengxin Chen; Ligang Fan; Shuang Feng; Xiaomin Cai; Huibo Wang
Journal:  Cancer Cell Int       Date:  2019-10-11       Impact factor: 5.722

8.  Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis.

Authors:  Xiaoming Huang; Fenglin Zhang; Dong He; Xiaoshuai Ji; Jiajia Gao; Wenqing Liu; Yunda Wang; Qian Liu; Tao Xin
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

9.  Screening TCGA database for prognostic genes in lower grade glioma microenvironment.

Authors:  Jie Ni; Siwen Liu; Feng Qi; Xiao Li; Shaorong Yu; Jifeng Feng; Yuxiao Zheng
Journal:  Ann Transl Med       Date:  2020-03

10.  MiR‑500a‑5p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5.

Authors:  Zhiyong Liu; Danying Su; Xiuying Qi; Jing Ma
Journal:  Mol Med Rep       Date:  2018-07-09       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.